Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea

Ki Ho Hong1, Gab Jung Kim2, Kyoung Ho Roh3

  • 1Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.

Insights

Updated guidelines for diagnosing coronavirus disease (COVID-19) in clinical laboratories incorporate new scientific data. Recommendations now include rapid molecular, antigen, and antibody tests, plus self-collected specimens for improved COVID-19 diagnosis.

Area of Science:

  • Clinical diagnostics
  • Virology
  • Public health

Background:

  • The COVID-19 pandemic necessitated rapid development and implementation of diagnostic testing strategies.
  • Existing laboratory guidelines required updates to reflect emerging scientific evidence and testing modalities.

Framework:

  • The updated guidelines provide a framework for clinical laboratories in Korea to diagnose COVID-19.
  • Recommendations are based on the latest scientific data and address evolving diagnostic needs.

Implementation:

  • Incorporates recommendations for rapid molecular assays, antigen tests, and antibody serology.
  • Includes guidance on the use of self-collected specimens for COVID-19 testing.
  • Revises previous recommendations to align with current best practices.

Implications:

  • Aims to enhance the accuracy and efficiency of COVID-19 laboratory diagnostics.
  • Supports clinical laboratories in effectively managing diagnostic testing during the pandemic.
  • Facilitates informed decision-making for patient care and public health surveillance.